Pharma News

Keep updating your pharma knowledge
24 Mar 2016

Cadila receives WHO finds faults in Moraiya vaccine plant in Gujarat

World Health Organization (WHO) cited violations of found “several major deviations” from standard procedures manufacturing and clinical standards.
Cadila stopped production of the vaccine at the plant and began a recall of all batches it made there since April 2015 after getting the notice in November, the WHO said. It also sells the vaccine in India.
Cadila’s staff at the plant falsified multiple quality control records and reports to hide contamination, and failed to implement a quality assurance system, the WHO said. Sterility failures were also not reported, nor investigated, the agency said among a series of concerns outlined in the letter. Microbiologists on site was “casual in his approach towards work”, and there was a “lack of supervision by the laboratory head,” the WHO notice said.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!